HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.

Abstract
Previous studies demonstrated selective inhibition of the BCR-ABL (breakpoint cluster region-Abelson murine leukemia oncogene) tyrosine kinase by RNA interference in leukemic cells. In this study, we evaluated the effect of BCR-ABL small interfering RNA (siRNA) and GFI1B siRNA silencing on chronic myeloid leukemia (CML) cells in myeloid blast crises. The GFI1B gene was mapped to chromosome 9 and is, therefore, located downstream of the BCR-ABL translocation in CML cells. Co-transfection of BCR-ABL siRNA and GFI1B siRNA dramatically decreased cell viability and significantly induced apoptosis and inhibited proliferation in K562 cells (P<0.0001) and primary advanced phase CML cells (P<0.0001) versus controls. Furthermore, combining of BCR-ABL siRNA and GFI1B siRNA significantly modified the expression of several relevant genes including Myc, MDR1, MRP1 and tyrosyl-phosphoproteins in primary CML cells. Our data suggest that silencing of both BCR-ABL siRNA and GFI1B siRNA is associated with an additive antileukemic effect against K562 cells and primary advanced CML cells, further validating these genes as attractive therapeutic targets.
AuthorsM Koldehoff, J L Zakrzewski, D W Beelen, A H Elmaagacli
JournalCancer gene therapy (Cancer Gene Ther) Vol. 20 Issue 7 Pg. 421-7 (Jul 2013) ISSN: 1476-5500 [Electronic] England
PMID23788109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GFI1B protein, human
  • Proto-Oncogene Proteins
  • RNA, Small Interfering
  • Repressor Proteins
  • Fusion Proteins, bcr-abl
Topics
  • Apoptosis
  • Cell Proliferation
  • Fusion Proteins, bcr-abl (genetics, metabolism)
  • Gene Expression
  • Gene Knockdown Techniques
  • Hematopoietic Stem Cells (metabolism)
  • Humans
  • K562 Cells
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Proto-Oncogene Proteins (genetics, metabolism)
  • RNA Interference
  • RNA, Small Interfering (genetics)
  • Real-Time Polymerase Chain Reaction
  • Repressor Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: